MedTrace Logo

Prolactin Levels in Type 2 Diabetic Patients With Stage III Periodontitis

NCT06941246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-04-23

No results posted yet for this study

Summary

evaluate the role of prolactin hormone in the pathogenesis of periodontitis by assessing its local gingival levels and assess clinical parameters in patients who have type two diabetes

Conditions

Interventions

PROCEDURE

Non Surgical Periodontal Treatment

the intervention includes Non Surgical Periodontal Therapy( scaling and root planning ),performed to reduce periodontal inflammation .Gingival Crevicular fluid samples will be collected before and after treatment to assess changes in prolactin hormone levels.

DEVICE

paper points

we use paper point to collect GCF sample

DEVICE

ELISA Kits

The samples are analyzed by ELISA kits to measure prolactin levels

Sponsors & Collaborators

  • Faculty of Dental Medicine for Girls

    lead OTHER_GOV

Principal Investigators

  • Naglaa El wakeel, Professer · Al-Azhar University

  • Zahraa Saeed, lecturer · Al-Azhar University

  • Olfat shaker, profeser · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-01-01
Completion
2025-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06941246 on ClinicalTrials.gov